COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,722 Articles (22,502 medRxiv, 8,220 bioRxiv)

Most recent first Previous |  Page 1676: Articles 16751-16760  | Next

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes
Sun, D., Sang, Z., Kim, J., Xiang, Y., Cohen, T., Belford, A. K., Huet, A., Conway, J. F., Sun, J., Taylor, D., Zhang, C., Huang, W., Shi, Y.
10.1101/2021.03.09.434592 — Posted: 2021-03-10
Structures and function of locked conformations of SARS-CoV-2 spike
Qu, K., Xiong, X., Ciazynska, K. A., Carter, A. P., Briggs, J. A. G.
10.1101/2021.03.10.434733 — Posted: 2021-03-10
Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351
Clark, J. J., Sharma, P., Bentley, E., Harding, A. C., Kipar, A., Neary, M., Box, H., Hughes, G., Patterson, E. I., Sharp, J., de Oliveira, T., Sigal, A., Hiscox, J. A., James, W. S., Carroll, M. W., Owen, A., Stewart, J. P.
10.1101/2021.03.10.434447 — Posted: 2021-03-10
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19
van der Wijst, M. G. P., Vazquez, S. E., Hartoularos, G. C., Bastard, P., Grant, T., Bueno, R., Lee, D. S., Greenland, J. R., Sun, Y., Perez, R., Ogorodnikov, A., Ward, A., Mann, S. A., Lynch, K. L., Yun, C., Havlir, D. V., Chamie, G., Marquez, C., Greenhouse, B., Lionakis, M. S., Norris, P. J., Dumont, L. J., Kelly, K., Zhang, P., Zhang, Q., Gervais, A., Le Voyer, T., Whatley, A., Si, Y., Byrne, A., Combes, A. J., Arkal, A., Song, Y. S., Fragiadakis, G. K., UCSF COMET consortium, , Kangelaris, K., Calfee, C. S., Erle, D. J., Hendrickson, C., Krummel, M. F., Woodruff, P. G., Langelier, C. R., Casanova, J.-L., Derisi, J. L., Anderson, M. S., Ye, C. J.
10.1101/2021.03.09.434529 — Posted: 2021-03-10
Structure and dynamics of the SARS-CoV-2 envelope protein monomer
Kuzmin, A., Orekhov, P., Astashkin, R., Gordeliy, V., Gushchin, I.
10.1101/2021.03.10.434722 — Posted: 2021-03-10
Impact of previous COVID-19 on immune response after a single dose of BNT162b2 SARS-CoV-2 vaccine
Velasco, M., Galan, M. I., Casas, M. L., Perez-Fernandez, E., Gonzalez-Pinyeiro, B., Castilla, V., Guijarro, C.
10.1101/2021.03.08.21253065 — Posted: 2021-03-10
Anti-SARS-CoV-2 Serology persistence over time in COVID-19 Convalescent Plasma Donors.
De Giorgi, V., West, K. A., Henning, A. N., Chen, L., Holbrook, M. R., Gross, R., Liang, J., Postnikova, E., Trenbeath, J., Pogue, S., Scinto, T., Alter, H. J., Cantilena, C. C.
10.1101/2021.03.08.21253093 — Posted: 2021-03-10
Efficacy of remdesivir in Japanese patients hospitalised with COVID-19: A large observational study using the COVID-19 Registry Japan
Tsuzuki, S., Hayakawa, K., Matsunaga, N., Terada, M., Suzuki, S., Ohtsu, H., Asai, Y., Kitajima, K., Saito, S., Uemura, Y., Shibata, T., Kondo, M., Izumi, K., Hojo, M., Mizoue, T., Yokota, K., Nakamura-Uchiyama, F., Saito, F., Sugiura, W., Ohmagari, N.
10.1101/2021.03.09.21253183 — Posted: 2021-03-10
COVID-19 is associated with multiple sclerosis exacerbations that are prevented by disease modifying therapies
Garjani, A., Middleton, R. M., Hunter, R., Tuite-Dalton, K. A., Coles, A., Dobson, R., Duddy, M., Hughes, S., Pearson, O. R., Rog, D., Tallantyre, E. C., das Nair, R., Nicholas, R., Evangelou, N.
10.1101/2021.03.08.21253141 — Posted: 2021-03-10
A High Rate of COVID-19 Vaccine Hesitancy Among Arabs: Results of a Large-scale Survey
Qunaibi, E. A., Helmy, M., Basheti, I., Sultan, I.
10.1101/2021.03.09.21252764 — Posted: 2021-03-10 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).